Literature DB >> 3303618

The mitral valve prolapse epidemic: fact or fiction.

R P Lewis, C F Wooley, A J Kolibash, H Boudoulas.   

Abstract

In spite of two decades of research, the precise relationship of anatomic mitral valve prolapse (floppy valve) to the neuroendocrine disorder (MVP syndrome) remains unclear. In all likelihood they are two separate genetic disorders which travel together in some fashion. Mitral valve prolapse is a common disorder but progressive mitral regurgitation usually occurs late in life and in only a few patients. Other complications such as bacterial endocarditis, stroke, and sudden death are far less common but can occur at younger ages. The neuroendocrine syndrome in civilian life is mainly seen in young females (interestingly the peak incidence years correspond to peak female sex hormone output) but can be seen in males when subjected to unusual stress such as military service. More recent echocardiographic studies have questioned whether all prolapsing valves are truly abnormal. It has been shown that echographic prolapse can be produced in normal subjects by reducing venous return and impaired venous return may be present in some patients with the MVP syndrome. However, clicks and murmurs are apparently not heard when normal valves prolapse. It is our opinion that the presence of a click or typical murmur requires some anatomic abnormality of the mitral valve. One wonders if minimal valve abnormality (noted and dismissed by Davies) is the valve abnormality present in many young females with MVP syndrome, and that it may remain a mild abnormality throughout life. Recent psychiatric studies suggest that MVP is present in 30% of patients with Panic Disorder. It is not clear that this psychiatric syndrome is the same thing as the MVP syndrome. In Devereux's study, anxiety proneness was no different in the MVP cohort than in relatives without MVP. It is possible that diagnostic mixing of two similar but separate disorders has occurred, as has been the case since World War I. Perhaps the most important question is whether young patients with MVP syndrome and no echocardiographic criteria for "floppiness" will develop progressive mitral regurgitation or other complications in later life. In other words, how often is MVP syndrome in a young individual without echocardiographic evidence of a floppy valve a precourser to eventual progressive mitral regurgitation? Are there two different populations? Because of the long course of the disorder, several more years of observation (and, it is hoped, prospective longitudinal study) will be required to answer this question.

Entities:  

Mesh:

Year:  1987        PMID: 3303618      PMCID: PMC2279723     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  30 in total

1.  NEUROCIRCULATORY ASTHENIA; STILL A COMMON AND IMPORTANT CLINICAL CONDITION.

Authors:  P D WHITE
Journal:  N Engl J Med       Date:  1964-12-24       Impact factor: 91.245

2.  From irritable heart to mitral valve prolapse: the Osler connection.

Authors:  C F Wooley
Journal:  Am J Cardiol       Date:  1984-03-01       Impact factor: 2.778

3.  Identification of the increased frequency of cardiovascular abnormalities associated with mitral valve prolapse by two-dimensional echocardiography.

Authors:  P A Chandraratna; A Nimalasuriya; D Kawanishi; P Duncan; B Rosin; S H Rahimtoola
Journal:  Am J Cardiol       Date:  1984-12-01       Impact factor: 2.778

4.  Sudden death in primary mitral valve prolapse.

Authors:  W A Pocock; C K Bosman; E Chesler; J B Barlow; J E Edwards
Journal:  Am Heart J       Date:  1984-02       Impact factor: 4.749

5.  Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study.

Authors:  D D Savage; R J Garrison; R B Devereux; W P Castelli; S J Anderson; D Levy; P M McNamara; J Stokes; W B Kannel; M Feinleib
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

6.  Mitral valve prolapse syndrome: the effect of adrenergic stimulation.

Authors:  H Boudoulas; J C Reynolds; E Mazzaferri; C F Wooley
Journal:  J Am Coll Cardiol       Date:  1983-10       Impact factor: 24.094

7.  Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement.

Authors:  B F Waller; A G Morrow; B J Maron; A A Del Negro; K M Kent; F J McGrath; R B Wallace; C L McIntosh; W C Roberts
Journal:  Am Heart J       Date:  1982-08       Impact factor: 4.749

8.  Abnormal cardiovascular regulation in the mitral valve prolapse syndrome.

Authors:  F A Gaffney; B C Bastian; L B Lane; W F Taylor; J Horton; J E Schutte; R M Graham; W Pettinger; C G Blomqvist
Journal:  Am J Cardiol       Date:  1983-08       Impact factor: 2.778

9.  The prevalence of ruptured chordae tendineae in the mitral valve prolapse syndrome.

Authors:  E Grenadier; G Alpan; S Keidar; A Palant
Journal:  Am Heart J       Date:  1983-04       Impact factor: 4.749

Review 10.  Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse.

Authors:  A Pasternac; J F Tubau; P E Puddu; R B Król; J de Champlain
Journal:  Am J Med       Date:  1982-12       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.